- FoI Number
- 2023-553
- Subject
- Asthma Medication
- Date Received
- 08/12/2023
- Request and Response
-
- How many patients have been treated (for any condition) in the last 4 months with:
- Benralizumab 0
- Dupilumab 0
- Omalizumab <5
- Reslizumab 0
- Mepolizumab <5
- Tezepelumab 0
- Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age groups:
- Age 6 – 11 0
- Age 12 – 17 0
- Age 18 and above <5
- How many patients have been treated in the last 4 months by the Respiratory Medicines Department ONLY with:
- Dupilumab
- Omalizumab
In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. This information is not recorded by pharmacy.
Where have given <5 answer this is because NHS Shetland considers that providing specific detail carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.
